Diffusion-weighted magnetic resonance for assessing fibrosis in Crohn's disease

Antonino Caruso1, Imerio Angriman2, Marco Scarpa2

  • 1Gastroenterology Unit of Castelfranco Veneto, Via dei Carpani 16/Z, 31033, Treviso, Italy. ant.caruso@hotmail.it.

Abstract

Insights

Diffusion-weighted imaging (DWI) can identify intestinal fibrosis in Crohn's Disease patients. This technique, using apparent diffusion coefficient (ADC) values, shows promise for evaluating disease severity in surgical candidates.

Area of Science:

  • Gastroenterology and Radiology
  • Medical Imaging Techniques
  • Fibrotic Disease Research

Background:

  • Intestinal fibrosis is a hallmark of Crohn's Disease (CD) lesions.
  • Mucosal biopsies may not fully represent transmural damage in CD.
  • Magnetic resonance enterography (MRE) offers a comprehensive view of bowel loops.

Purpose of the Study:

  • To evaluate the efficacy of diffusion-weighted imaging (DWI) in identifying intestinal fibrosis in Crohn's Disease patients.
  • To assess DWI's ability to detect fibrosis in patients scheduled for surgery.
  • To correlate DWI findings with histopathological assessments of fibrosis.

Main Methods:

  • Thirty Crohn's Disease patients undergoing surgery for stricturing ileo-colonic disease were enrolled.
  • All patients underwent MRE with DWI prior to surgery.
  • Histopathological examination with fibrosis and inflammation scoring served as the gold standard.

Main Results:

  • Apparent diffusion coefficient (ADC) values significantly correlated with fibrosis and inflammation scores.
  • A strong correlation was observed between bowel wall thickness and fibrosis score.
  • DWI identified fibrosis with a cut-off ADC value of <1.1×10⁻³ mm²/s (AUC=0.83, sensitivity 72%, specificity 94%).

Conclusions:

  • Diffusion-weighted imaging (DWI) shows potential for identifying intestinal fibrosis in Crohn's Disease.
  • ADC values derived from DWI can aid in assessing fibrotic changes in the intestinal wall.
  • DWI may be a valuable tool for evaluating Crohn's Disease patients, particularly those considered for surgery.